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We previously reported that desmosomes play a key role
in the adhesion of corneocytes, and their digestion by
two types of serine proteases leads to desquamation.
Patients with recessive X-linked ichthyosis show hyper-
keratosis attributable to desmosomes, associated with an
increased content of cholesterol sulfate (CS) and an
increased thickness of stratum corneum. In this study,
therefore, we examined the possibility that CS provokes
the abnormal desquamation, acting as a protease
inhibitor. Scaling was induced on mice after topical
application of chymostatin and leupeptin. Visible scale
was also observed on mice after topical application of
CS. We found that the stratum corneum thickness of CS-
treated mice was increased in comparison with that of
vehicle-treated mice. The thickness of the epidermis and
the labeling index with proliferating cell nuclear antigen
Recessive X-linked ichthyosis, which is caused by adeficiency of steroid sulfatase, is a disease exhibit-ing hyperkeratosis accompanied by accumulation ofcholesterol sulfate (CS). It has long been thoughtthat lipids, especially CS, act as corneocyte cohesion
elements. Cholesterol-lowering substances are known to induce scaling
disorder (Williams and Elias, 1987; Williams et al, 1987), whereas
topical application of CS induced scaling without acanthosis or increased
labeling index (Maloney et al, 1984; Elias et al, 1984). The highly
cohesive ungulate hoof is particularly rich in CS (Wertz and Downing,
1984); however, no significant differences in CS content were found
between tightly cohesive stratum corneum of the palm, and the loosely
cohesive stratum corneum of the upper arm (Serizawa et al, 1992).
Thus, the relationship between CS and accumulated stratum corneum
is unclear. Williams suggested the possibility that the failure to
desquamate in recessive X-linked ichthyosis may be due to CS-
mediated inhibition of desmosome proteolysis (Williams, 1991). We
have investigated the mechanism of desquamation in stratum corneum,
showing that desmosomes play a key role in the adhesion of corneocytes,
and that their digestion by two types of serine proteases leads to
desquamation (Suzuki et al, 1993, 1994). Lundstro¨m and Egelrud also
reported that chymotrypsin-like enzyme activity in the stratum corneum
may play a role in the desquamation process (Lundstro¨m and Egelrud,
1991; Sondell et al, 1995). It was reported that numerous desmosomal
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from CS-treated mice was almost the same as that from
vehicle-treated mice. Moreover, in the stratum corneum
of CS-treated mice, the content of desmosomes was
higher than that in vehicle-treated mice. CS also
inhibited the protease-induced cell dissociation of
human stratum corneum sheets. In vitro, CS competi-
tively inhibited both types of serine protease: the Ki for
trypsin was 5.5 3 10–6 M and that for chymotrypsin was
2.1 3 10–6 M. These results indicate that CS retards
desquamation by acting as a protease inhibitor. Thus,
accumulation of stratum corneum in recessive X-linked
ichthyosis may be a result of the inhibition by excessive CS
of proteases involved in the dissolution of desmosomes,
required for desquamation of the stratum corneum. Key
words: chymotrypsin/desmosome/ichthyosis/trypsin. J Invest
Dermatol 111:189–193, 1998
structures remained in the outermost layers of the stratum corneum in
recessive X-linked ichthyosis (Anton-lamprecht, 1974; Bazex et al,
1978; Mesquita-Guimaraes, 1981). Because CS inhibited the serine
protease, acrosin, required for normal sperm capacitation (Burck and
Zimmerman, 1980), in this study we examined the possibility that CS
acts as a protease inhibitor, retarding desquamation of stratum corneum.
MATERIALS AND METHODS
Animals and topical application Cholesterol 3-Sulfate (CS, Sigma, St.
Louis, MO) and chymostatin (Peptide Institute, Osaka, Japan) were dissolved
in dimethyl sulfoxide (DMSO, Wako, Japan) to prepare a 10 mM solution.
Leupetin (Peptide Institute) was dissolved in distilled water to prepare a 10 mM
solution. Eighty microliters of CS solution, chymostatin and leupeptin, DMSO
and distilled water, or DMSO alone was applied to the backs of hairless mice
(Hos:HR-1) once a day. Six to 8 wk old male hairless mice were obtained
from Hoshino (Saitama, Japan). After 3 d, biopsy and collection of stratum
corneum by tape-stripping was undertaken.
Histologic observations Biopsy samples were fixed in 10% formalin and
embedded in paraffin. The sections were stained with hematoxylin and eosin.
Measurements of the thickness of the epidermis were made with a light
microscope equipped with a CCD camera and image analysis system (Olympus
XL-10, Japan). The sections were stained with proliferating cell nuclear antigen
and positive cells were counted.
Electron microscopy Biopsy samples were fixed in half-strength
Karnovskey’s fixative, divided, and processed through reduced 1.0%
osmium tetroxide followed by embedding in an Epon-eposy mixture. Ultrathin
sections were viewed in an electron microscope (H7100, Hitachi, Tokyo,
Japan) after further contrasting in lead citrate and uranyl acetate. The number
of stratum corneum layers was counted in a blinde manner.
Detection of desmosomes in the stratum corneum Desmosomal proteins
were extracted from tape-stripped stratum corneum in a buffer containing
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0.1 M Tris HCl pH 9, 9 M urea, 2% sodium dodecyl sulfate, and 1%
mercaptoethanol (200 µl of buffer per 2 mg stratum corneum) for 15 h at 37°C
(Lundstro¨m and Egelrud, 1990). The extracts were prepared by mixing them
with a Laemmli’s sample buffer (Laemmli, 1970), followed by heating on a
boiling water bath for 10 min. After centrifugation, the supernatant was analyzed
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in 10% gel.
Electophoretic transfer of proteins from the gel to PVDF membrane (Applied
Biosystems, CA) was followed by immunostating with a Promega Protoblot
Western Blot AP System (Promega, Madison, WI). Monoclonal antibody, anti-
DG I, obtained by Boehringer (Mannheim, Germany), was used for detection
of desmosomal glycoprotein, desmoglein I.
Cell dissociation from the stratum corneum sheet The stratum corneum
sheet was obtained from the back of a volunteer 5 d after sun exposure. One
milligram of strateum corneum sheet was incubated in 1 ml detergent mixture
(8 mM DMDAO and 2 mM sodium dodecyl sulfate) with CS, phosphatidyl-
choline (Sigma, St. Louis, MO), palmitic acid (Sigma), taurocholic acid (Sigma),
or each vehicle, containing 60 µg kanamycin at 37°C for 24 h (Takahashi et al,
1987). The number of released cells in the detegent mixture was counted using
a Burker-Turk hemocytometer.
Assay for inhibitory behavior of cholesterol sulfate Crystalline porcin
pancreatic trypsin (Wako, Osaka, Japan) and crystalline bovine pancreatic
chymotrypsin (Sigma) were used to examine the inhibitory behavior of CS.
Trypsin activity or chymotrypsin activity was examined by using Boc-Phe-
Ser-Arg-MCA (3107-V) or Suc-Leu-Leu-Val-Tyr-MCA (3120-V) (Peptide
Institute), respectively, as the substrate. Inhibitory activities of phosphatidyl-
choline, palmitic acid, cholesterol, and taurocholic acid were also examined.
All assays were performed at 37°C in 0.1 M Tris HCl (pH 8.0).
Statistics The significance of difference was tested using the unpaired
Student’s t test.
RESULTS
Application of CS increases the stratum corneum thickness and
induces abnormal scaling Visible scales were observed on the
backs of mice 3 d after topical application of CS (Fig 1). Biopsy taken
at this point showed increased thickness of the stratum corneum layer
from mice treated with CS in comparison with that from vehicle-
treated mice (Fig 2). Moreover, quantitative studies showed an
increased number of stratum corneum layers of CS- versus vehicle-
treated skin (Fig 3). Furthermore, the thickness of the living part of
the epidermis from CS-treated mice was the same as that from vehicle-
treated mice (data not shown). Finally, there were no differences
between CS-treated and vehicle-treated skin in the labeling index with
proliferating cell nuclear antigen, a measure of proliferative acitivity
(data not shown). These results show the effect of CS on increasing
the number of cell layers, the thickness, and the abnormal scaling of
the stratum corneum. To examine whether CS acts as a detergent to
disrupt enzyme function, we also applied phosphatidylcholine as
amphopatic lipid to the backs of mice. Both daily treatment of 4.88 mg
CS per ml (10 mM) and daily treatment of 0.488 mg CS per ml
(1 mM) induced scales on the backs of mice after topical application;
however, topical application of 4.88 mg phosphatidylcholine per ml
did not show an increase in the number of scales compared with
vehicle treatment (data not shown).
The increased content of desmosomal protein in the stratum
corneum of CS-treated mice The stratum corneum of mice
treated with CS or vehicle for 3 d was obtained by tape-stripping and
the extracted proteins were subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. The separated proteins were trans-
ferred to PVDF membranes and reacted with anti-DG I. As seen in
Fig 4, the tendency of the increased content of desmoglein I was
noted in the stratum corneum of CS-treated mice (p 5 0.0503, n 5
3). These results suggest that degradation of desmosomes was inhibited
by the topical application of CS.
CS inhibited cell dissociation from the stratum cornuem
sheet CS inhibited cell dissociation in this assay in a concentration-
dependent manner (Fig 5). One hundred micromoles and 1 mM of
CS inhibited cell dissociation to 64.0% and 56.9% of the 100% controls,
respectively. Other amphopathic lipids, 1 mM phosphatidylcholine,
Figure 1. Increasing the abnormal scales on the backs of mice after
topical application of CS. Skin surface appearance of a normal vehicle-
treated control mouse (a) versus a cholesterol sulfate-treated mouse (b). Animals
were treated with 80 µl daily for 3 d.
Figure 2. Increased thickness of the stratum corneum layer from mice
treated with CS. (a) The stratum corneum of vehicle-treated control. (b) The
stratum corneum from animals treated with 80 µl cholesterol sulfate (10 mM)
daily for 3 d. Scale bars: 5 µm.
1 mM palmitic acid, and 1 mM taurocholic acid did not inhibit cell
dissociation from the stratum corneum sheet (Table I). These results
show that CS acts directly on cell shedding in the stratum corneum
and the effect is not simply a detergent effect.
Inhibition of trypsin and chymotrypsin by CS Phospha-
tidylcholine, palmitic acid, cholesterol, and taurocholic acid did not
show inhibitory activity in the assay using trypsin (Fig 6). CS was
found to be a potent inhibitor of trypsin and chymotrypsin in vitro.
VOL. 111, NO. 2 AUGUST 1998 CHOLESTEROL SULFATE INHIBITS PROTEASES 191
Figure 3. Application of cholesterol sulfate resulted in an increased
number of stratum corneum layers as compared with vehicle treatment
(n 5 6, mean 6 SD). Cholesterol sulfate versus control, p , 0.01.
Figure 4. The level of anti-DG I-reactive protein in cholesterol sulfate-
treated mice was higher than that of vehicle-treated mice (n 5 3,
mean 6 SD).
Figure 5. CS inhibited cell dissociation from the stratum cornuem
sheet. The stratum corneum sheet (1 mg) was incubated in a detegent mixture
for 24 h at 37°C with cholsterol sulfate (n 5 3, mean 6 SD). Significant
differences: 100 µM cholesterol sulfate versus control, p , 0.05; 1 mM
cholesterol sulfate versus control, p , 0.05.
A double reciprocal plot showed that the inhibition of trypsin by
CS is competitive (Fig 7a), and a Dixon plot gave a Ki value of
5.5 3 10–6 M (Fig 7b). Similar procedures showed that CS is also
a competitive inhibitor of chymotrypsin with a Ki value of 2.1 3
10–6 M (Fig 8a, b).
Figure 6. CS inhibited trypsin in the enzyme assay system in vitro. Two
micromoles of CS, 2 µM of phosphatidylcholine, 2 µM of palmitic acid, 2 µM
of cholesterol, and 2 µM of tauroric acid were examined for inhibitory activity
using porcin pancreatic trypsin (n 5 3, mean 6 SEM). Significant difference:
cholesterol sulfate versus control, p , 0.05.
Figure 7. Cholesterol sulfate is a competetive inhibitor of trypsin. (a)
Lineweaver–Burk plot of the inhibition of trypsin by cholesterol sulfate (n,
3 3 10–7 M; u, 2 3 10–7 M); s, no cholesterol sulfate. (b) Dixon plot of
trypsin by cholesterol sulfate (s, 2.0 3 10–5 M 3107-V; n, 1.0 3 10–5 M
3107-V; u, 5.0 3 10–6 M 3107-V; 1, 2.5 3 10–6 M 3107-V).
Table I. One millimole of CS inhibited cell dissociation from
stratum corneum sheet
Relativity (%) of
the control
Lipids Mean SD Significance versus control
1 mM cholesterol sulfate 56.9 9.55 p , 0.05
1 mM palmitic acid 105.8 14.49 n.s.
1 mM phosphatidylcholine 134.1 25.18 n.s.
1 mM taurocholic acid 89.4 5.70 n.s.
Chymostatin and leupeptin also induced scales on the backs of
mice after topical application It has been thought that CS has
multiple functions, e.g., acting as a surfactant. To explore the possibility
that CS acts as an protease inhibitor, we examined the effect of
commercially available protease inhibitors in vivo by topical application
on skin. Large scales were observed on the backs of mice after topical
application of 10 mM chymostatin and 10 mM leupeptin (Fig 9a).
The degree of scale was less obvious than that of the case of CS. Scales
were assessed by measurement of their area using a binary image
(Fig 9b). Mice undergoing topical application of chymostatin and
leupeptin had an increased number of scales compared with vehicle-
treated mice (Fig 9c). Because protease inhibitors also induced scales
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in vivo after topical application, the possibility that CS acts as an
inhibitor in the stratum corneum is indicated.
DISCUSSION
The mechanism of regulation of desquamation in the stratum corneum
is still unknown. We have shown previously that two types of serine
protease are involved, and that degradation of desmosomes leads to
desquamation (Suzuki et al, 1993, 1994). Lundstro¨m and Egelrud also
reported chymotrypsin-like enzyme activity in the stratum corneum
(Lundstro¨m and Egelrud, 1991; Sondell et al, 1995). The disorder of
cornification, recessive X-linked ichthyosis, exhibits retention hyper-
keratosis accompanied by accumulation of CS. Because CS inhibits
the serine protease, acrosin (Burck and Zimmerman, 1980), we decided
to examine the possibility that CS also plays a role as an inhibitor in
desquamation.
Increased thickness of the stratum corneum reportedly is induced
by topical application of CS without acanthosis, increased labeling
index, or dermal inflammation (Maloney et al, 1984; Elias et al, 1984).
We also observed scaling on the backs of hairless mice after topical
applications of CS, and confirmed that there was no difference between
CS-treated and vehicle-treated mice in the thickness of the epidermis
and the labeling index with proliferating cell nuclear antigen, an index
of proliferative activity. In contrast, the number of stratum corneum
layers and the content of desmoglein I in the stratum corneum of CS-
treated mice were higher than those in vehicle-treated mice. These
results suggest that digestion of desmosomal proteins is inhibited by
CS treatment.
Figure 8. Cholesterol sulfate is a competitive inhibitor of chymotrypsin.
(a) Lineweaver–Burk plot of the inhibition of chymotrypsin by cholesterol
sulfate (n, 2.98 3 10–6 M; u, 2.23 3 10–6 M); s, no cholesterol sulfate. (b)
Dixon plot of chymotrypsin by cholesterol sulfate (s, 1.21 3 10–4 M 3120-V;
n, 6.06 3 10–5 M 3120-V; u, 3.03 3 10–5 M 3120-V).
Figure 9. Increasing the abnormal scales
on the backs of mice after topical
application of chymostatin and leupeptin.
Skin surface appearance of a normal vehicle-
treated control mouse (a-1) versus a chymostatin
and leupeptin treated mouse (a-2) and its binary
images of a normal vehicle-treated control
mouse (b-1) versus a chymostatin and leupeptin
treated mouse (b-2). Scales were assessed by
measurement of its area using a binary image
and were quantitated by NIH image. Increased
scales on mice by topical application of
chymostatin and leupeptin in comparison with
that from vehicle-treated mice (c) (n 5 4,
mean 6 SD). Cholesterol sulfate versus control,
p , 0.05.
It has been reported that CS also acts as a second messenger for
protein kinase C, hence the effects of CS on stratum corneum retention
might be mediated indirectly (Chida et al, 1995). To avoid such effects
of CS on living keratinocytes, we examined the effect of CS in the
stratum corneum sheets. We found that the cell dissociation from
the stratum corneum sheet was inhibited by CS, suggesting that CS
acts directly on the cell shedding in the stratum corneum.
Finally, we examined the extent of the inhibitory properties of CS
using commercially available crystallized trypsin and chymotrypsin as
model enzymes, because enzymes in the stratum corneum were shown
to be trypsin-like and chymotrypsin-like proteases (Suzuki et al, 1993,
1994). CS competitively inhibited both trypsin and chymotrypsin with
Ki values of 5.5 3 10
–6 M and 2.1 3 10–6 M, respectively. Thus,
in vitro experiments for inhibitory properties of CS on model enzymes
showed that Ki values had micromolar concentrations. We used
1–10 mM CS in the stratum corneum sheet assay and topical application,
because there may be some difficulties with CS penetration into the
stratum corneum. Maloney et al (1984) also reported that µ5–10 mM
of CS was needed to induce abnormal scales.
Although leupeptin and chymostatin showed more potent inhibitors
of cell dissociation than CS in the stratum corneum sheet assay (data
not shown), application of CS results in more obvious stratum corneum
scaling compared with the mixture of leupeptin and chymostatin. This
may reflect a high affinity of CS for the stratum corneum intercellular
lipids, and for the physicochemical properties of CS itself (Williams,
1991).
To examine whether CS acts as a detergent to disrupt enzyme
function, amphopatic lipids were tested in looking for scaling in vivo,
the cell dissociation assay, and the enzyme assay in vitro. Topical
application of phosphatidylcholine did not induce scales. The cell
dissociation from the stratum corneum was not inhibited by phospha-
tidylcholine, palmitic acid, and taurocholic acid. In the enzyme assay
system in vitro, phosphatidylcholine, palmitic acid, cholesterol, and
taurocholic acid did not show inhibitory activity. These results show
the effect is not simply a detergent effect.
The above results indicate that CS influences desquamation by acting
as a serine protease inhibitor. Further, the accumulated stratum corneum
in recessive X-linked ichthyosis may be caused by the inhibition of
trypsin-like and chymotrypsin-like proteases by excessive CS. This
could account for the abnormal persistence of numerous desmosomal
structures in the outermost layers of the stratum corneum in this disease
(Anton-Lamprecht, 1974; Bazex et al, 1978; Mesquita-Guimaraes,
1981). Our results suggest a possible new role of CS as an inhibitor
in desquamation. In addition, quantitative lipid analysis of porcine
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epidermal strata revealed that CS exhibited its concentration in the
deeper stratum corneum and then abruptly decreased in the surface
layer (Cox and Squier, 1986). Thus, CS might regulate not only
desquamation in pathologic stratum corneum, but also normal
desquamation; the content of CS in the stratum corneum might
influence the desquamation process in the normal stratum corneum.
The authors wish to express their gratitude to Prof. Dr P. M. Elias for helpful suggestions.
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